Dhampur Bio Organics Ltd is Rated Hold

1 hour ago
share
Share Via
Dhampur Bio Organics Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Dhampur Bio Organics Ltd is Rated Hold

Current Rating and Its Significance

MarketsMOJO’s 'Hold' rating for Dhampur Bio Organics Ltd indicates a neutral stance on the stock, suggesting that investors should neither aggressively buy nor sell at this juncture. This rating reflects a balance between the company’s strengths and weaknesses across multiple parameters. The Mojo Score currently stands at 50.0, a moderate level that supports a cautious approach. This score improved from 40.0 when the rating was previously 'Sell', signalling some positive developments but not enough to warrant a more optimistic recommendation.

Quality Assessment: Below Average Fundamentals

As of 13 July 2026, Dhampur Bio Organics Ltd exhibits below average quality metrics. The company has experienced a negative compound annual growth rate (CAGR) of -16.95% in operating profits over the past five years, indicating challenges in sustaining profitability growth. Its ability to service debt remains constrained, with a high Debt to EBITDA ratio of 8.10 times, which is a concern for financial stability. Furthermore, the average Return on Equity (ROE) stands at a modest 2.89%, reflecting limited profitability generated from shareholders’ funds. These factors collectively temper the company’s fundamental strength and contribute to the cautious 'Hold' rating.

Valuation: Attractive Pricing Relative to Peers

Despite the fundamental challenges, the stock’s valuation appears attractive. The company’s Return on Capital Employed (ROCE) is 3.5%, and it trades at an Enterprise Value to Capital Employed ratio of just 0.9, suggesting the market values the company below its capital base. This discount relative to peer valuations offers a potential margin of safety for investors. Additionally, the Price/Earnings to Growth (PEG) ratio is 0.6, indicating that the stock’s price growth is favourable compared to its earnings growth. Such valuation metrics support the 'Hold' rating by signalling that the stock is reasonably priced, if not undervalued, in the current market environment.

Financial Trend: Positive Recent Performance

The latest data as of 13 July 2026 shows encouraging signs in the company’s financial trend. The Profit Before Tax excluding Other Income (PBT LESS OI) for the quarter ending March 2026 surged to ₹63.76 crores, representing a remarkable growth of 5191.3% compared to the previous four-quarter average. The Profit After Tax (PAT) for the latest six months also improved to ₹63.17 crores. Operating profit to interest coverage ratio reached a high of 5.76 times, indicating enhanced ability to meet interest obligations. These positive developments suggest improving operational efficiency and profitability, which partially offset the longer-term fundamental weaknesses.

Technical Outlook: Mildly Bullish Momentum

From a technical perspective, the stock exhibits mildly bullish characteristics. As of 13 July 2026, the stock price has gained 1.16% on the day, with a one-week gain of 1.12%. However, it has experienced some short-term volatility, with a one-month decline of 0.96% and a three-month drop of 5.27%. Over the longer term, the stock has delivered robust returns, rising 42.21% over six months and 43.11% year-to-date. The one-year return stands at a healthy 23.01%. This price action suggests that while short-term fluctuations exist, the overall trend remains positive, supporting the 'Hold' rating as investors weigh momentum against fundamental concerns.

Additional Considerations: Market Participation and Company Size

Dhampur Bio Organics Ltd is classified as a microcap within the sugar sector. Notably, domestic mutual funds currently hold no stake in the company. Given that mutual funds often conduct thorough on-the-ground research, their absence may indicate reservations about the company’s price or business model. This lack of institutional participation adds an element of caution for investors, reinforcing the rationale behind the 'Hold' rating.

Summary for Investors

In summary, Dhampur Bio Organics Ltd’s 'Hold' rating reflects a nuanced view. The company faces fundamental challenges, including weak long-term profit growth and high leverage, which weigh on its quality grade. However, attractive valuation metrics and recent improvements in profitability and interest coverage provide some offsetting positives. The technical trend shows moderate bullishness, but the absence of institutional backing suggests investors should remain cautious. For those considering exposure to this stock, the current rating advises monitoring developments closely while recognising that the stock is fairly valued and not positioned for aggressive buying or selling at present.

Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!

  • - Accelerating price action
  • - Pure momentum play
  • - Pre-peak entry opportunity

Jump In Before It Peaks →

Looking Ahead

Investors should continue to monitor Dhampur Bio Organics Ltd’s operational performance and financial health, particularly its ability to reduce debt and improve profitability sustainably. The company’s valuation remains a key attraction, but any deterioration in fundamentals or adverse sector developments could impact the stock’s outlook. Conversely, sustained profit growth and increased institutional interest could prompt a reassessment of the rating in the future.

Conclusion

Dhampur Bio Organics Ltd’s current 'Hold' rating by MarketsMOJO, last updated on 06 February 2026, is supported by a balanced assessment of quality, valuation, financial trends, and technical factors as of 13 July 2026. This rating advises investors to maintain a neutral stance, recognising both the risks and opportunities inherent in the stock at this time.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News